Related Experiment Video
Updated: May 2, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Structural and biochemical characterization of the KLHL3-WNK kinase interaction important in blood pressure
Frances-Rose Schumacher1, Fiona J Sorrell2, Dario R Alessi1
1*MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, U.K.
Abstract:
WNK1 [with no lysine (K)] and WNK4 regulate blood pressure by controlling the activity of ion co-transporters in the kidney. Groundbreaking work has revealed that the ubiquitylation and hence levels of WNK isoforms are controlled by a Cullin-RING E3 ubiquitin ligase complex (CRL3KLHL3) that utilizes CUL3 (Cullin3) and its substrate adaptor, KLHL3 (Kelch-like protein 3). Loss-of-function mutations in either CUL3 or KLHL3 cause the hereditary high blood pressure disease Gordon's syndrome by stabilizing WNK isoforms. KLHL3 binds to a highly conserved degron motif located within the C-terminal non-catalytic domain of WNK isoforms. This interaction is essential for ubiquitylation by CRL3KLHL3 and disease-causing mutations in WNK4 and KLHL3 exert their effects on blood pressure by disrupting this interaction. In the present study, we report on the crystal structure of the KLHL3 Kelch domain in complex with the WNK4 degron motif. This reveals an intricate web of interactions between conserved residues on the surface of the Kelch domain β-propeller and the WNK4 degron motif. Importantly, many of the disease-causing mutations inhibit binding by disrupting critical interface contacts. We also present the structure of the WNK4 degron motif in complex with KLHL2 that has also been reported to bind WNK4. This confirms that KLHL2 interacts with WNK kinases in a similar manner to KLHL3, but strikingly different to how another KLHL protein, KEAP1 (Kelch-like enoyl-CoA hydratase-associated protein 1), binds to its substrate NRF2 (nuclear factor-erythroid 2-related factor 2). The present study provides further insights into how Kelch-like adaptor proteins recognize their substrates and provides a structural basis for how mutations in WNK4 and KLHL3 lead to hypertension.
Insights
Structural insights reveal how mutations in WNK4 and KLHL3 disrupt protein interactions, leading to Gordon's syndrome and hypertension by stabilizing WNK isoforms. This study details the KLHL3-WNK4 complex structure.
Area of Science:
- Molecular Biology
- Structural Biology
- Genetics
Background:
- WNK kinases (WNK1 and WNK4) regulate blood pressure via kidney ion co-transporters.
- The Cullin-RING E3 ubiquitin ligase complex (CRL3KLHL3), comprising CUL3 and KLHL3, controls WNK isoform ubiquitylation and levels.
- Mutations in CUL3 or KLHL3 cause Gordon's syndrome (hypertension) by stabilizing WNK isoforms.
Purpose of the Study:
- To determine the crystal structure of the KLHL3 Kelch domain bound to the WNK4 degron motif.
- To elucidate the molecular interactions governing KLHL3-WNK4 binding and the impact of disease-causing mutations.
- To compare the interaction of KLHL2 with WNK4 to that of KLHL3.
Main Methods:
- X-ray crystallography was used to determine the structures of KLHL3-WNK4 degron and KLHL2-WNK4 degron complexes.
- Analysis of conserved residues and interface contacts within the protein complexes.
- Comparison of KLHL protein-substrate interactions.
Main Results:
- The crystal structure reveals extensive interactions between the KLHL3 Kelch domain and the WNK4 degron motif.
- Disease-associated mutations in WNK4 and KLHL3 disrupt these critical interface contacts, impairing binding.
- KLHL2 binds WNK4 similarly to KLHL3, but distinct from KEAP1-NRF2 interactions.
Conclusions:
- The study provides a structural basis for understanding how Kelch-like proteins recognize their substrates.
- Disruption of the KLHL3-WNK4 interaction by mutations explains the mechanism underlying Gordon's syndrome.
- Structural insights offer a foundation for developing therapeutic strategies targeting hypertension.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Potassium-Sparing Diuretics
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Non-Canonical Wnt Signaling Pathways
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

